Dr. Vivian Vega reviews several interesting Infectious Diseases cases she has managed over the last several years, and includes relavant ID-related pearls about diagnosis and management. From an infectious diseases conference recorded in September 2020.
With the help of the popular online web site Snopes.com, and a hint of inspiration from the “Mythbusters,” Dr Oehler reviews contemporary myths and online conspiracy theories about COVID-19 and the SARS 2 Coronavirus. The author tackles such myths as whether government statistics about coronavirus deaths are accurate, predictions that the pandemic would occur in …
Dr. Seetha Lakshmi, Associate Professor and Infectious Diseases Physician at the University of South Florida, presents an overview of this novel pathogen. Responsible for a December 2019 outbreak originating in China’s Hubei province, the virus has now been responsible for thousands of deaths and has spread to multiple countries outside of China with recent outbreaks …
Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, discusses the recent updates to the diagnosis and management of community acquired pneumonia. Dr. Klinkova begins her talk by referring to the recently introduced IDSA-ATS guidelines, released in August, 2019. She then discusses updates in the microbiology of CAP, including the …
In this updated talk, Dr. Oehler discusses the assessment and management of infections of central catheters. Dr. Oehler begins his talk by covering the epidemiology of central line infections, including the most common organisms involved, and covers the different types of intravascular devices. He then discusses the mechanisms by which central line associated bloodstream infections …
Dr. Pasikhova discusses the history of the Pneumocystis pathogen, its epidemiology, and how it is transmitted to patients. She also discusses the pathophysiology of the infection in the context of the immunocompromised cancer patient. The role of steroids in the aquisition of PJP infection is touched upon. Lastly, Dr. Pasikhova describes prophylaxis against Pneumocystis, including …
Dr. Quilitz discusses the risk factors behind neutropenic fever. He then discusses prominent bacterial, fungal, and viral pathogens which cause infections in the immunocompromised cancer patient. Lastly, he discusses antimicrobial options to prevent or treat opportunistic infections in these patients.
Dr. John Greene discusses different patterns of consolidation visible on lung imaging and the differential diagnosis for pneumonia in immunocompetent and immunocompromised patients. He reviews CT imaging for ground glass opacities, consolidation, nodular opacities, and nodular cavitary lesions on the lungs. He covers interstitial pulmonary fibrosis, pulmonary alveolar proteinosis, community acquired viral and bacterial pneumonia, …
Dr. Pandya reviews the relationship between fever and infection, including fever classifications, various fever patterns, fever severity, and fevers associated with specific conditions.
Dr. Rod Quilitz, ID clinical pharmacist and Moffitt Cancer Center and Research Institute, discusses the Moffitt approach to the identification, assessment, and management of invasive fungal infections in the immunocompromised host.
